Spexis AG (STU:29Y) 3-Year EBITDA Growth Rate : 60.30% (As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Spexis AG 3-Year EBITDA Growth Rate?

Spexis AG's EBITDA per Share for the six months ended in Jun. 2023 was €-0.07.

During the past 3 years, the average EBITDA Per Share Growth Rate was 60.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 43.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Spexis AG was 68.40% per year. The lowest was -42.00% per year. And the median was 18.80% per year.

Competitive Comparison of Spexis AG's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Spexis AG's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Spexis AG's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Spexis AG's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Spexis AG's 3-Year EBITDA Growth Rate falls into.

Spexis AG 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Spexis AG (STU:29Y) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Spexis AG 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Spexis AG's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Spexis AG (STU:29Y) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Spexis AG (STU:29Y) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

SPEXz:UK SPEX:Switzerland

Address

Hegenheimermattweg 125, Allschwil, CHE, CH-4123

Website

https://www.polyphor.com

Spexis AG is a clinical-stage biopharmaceutical company. The company is engaged in the discovery and development of antibiotics and other specialty pharma products for severe or life-threatening diseases. The company's lead product, murepavadin, is in Phase III development against Pseudomonas aeruginosa - recognized as a critical priority 1 pathogen by World Health Organization. It has one operating segment focusing on the research and development and prospective commercialization of respiratory therapeutics addressing high unmet medical needs.

Spexis AG (STU:29Y) Headlines

No Headlines